Workflow
深企发布全自动AI血管介入手术机器人 预计下半年投入动物手术

Core Insights - Shenzhen-based Ruixin Medical has launched a fully automated AI vascular interventional surgery robot, marking the entry into a "fully automated" intelligent phase in vascular interventional diagnosis and treatment [1] - This robot represents one of the first industrialized results in the key area of "medical robots + AI medical devices," enabling collaboration among doctors, intelligent systems, and execution terminals [1] - The robot allows doctors to issue clinical tasks through natural language interactions, which the intelligent system translates into executable operational goals, ultimately performed by the execution terminal [1] Product Development - The fully automated AI vascular interventional surgery robot has completed prototype production and simulation experiments, with expectations to finish AI automated animal surgeries in the second half of this year [1] - Ruixin Medical's founder and CEO, Zheng Lingxiao, indicated that in the future, simple and repetitive surgical procedures could be autonomously completed by AI surgical robots under the supervision of doctors [1] - For more complex surgeries, AI surgical robots are expected to provide stronger assistance to experts [1]